These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
27. Addition of heparin to contrast media is associated with increased bleeding and peripheral vascular complications during percutaneous coronary intervention with bivalirudin and drug-eluting stents. Rha SW; Kuchulakanti PK; Pakala R; Cheneau E; Pinnow E; Gebreeyesus A; Aggrey G; Pichard AD; Satler LF; Kent KM; Lindsay J; Waksman R Cardiovasc Radiat Med; 2004; 5(2):64-70. PubMed ID: 15464942 [TBL] [Abstract][Full Text] [Related]
28. Efficacy and safety of bivalirudin in patients receiving clopidogrel therapy after diagnostic angiography for percutaneous coronary intervention in acute coronary syndromes. Feldman DN; Minutello RM; Bergman G; Moussa I; Wong SC Catheter Cardiovasc Interv; 2010 Oct; 76(4):513-24. PubMed ID: 20882655 [TBL] [Abstract][Full Text] [Related]
29. Bivalirudin versus heparin plus a glycoprotein IIb/IIIa inhibitor in patients with non-ST-segment elevation myocardial infarction undergoing percutaneous coronary intervention after clopidogrel pretreatment: pooled analysis from the ACUITY and ISAR-REACT 4 trials. Ndrepepa G; Neumann FJ; Deliargyris EN; Mehran R; Mehilli J; Ferenc M; Schulz S; Schömig A; Kastrati A; Stone GW Circ Cardiovasc Interv; 2012 Oct; 5(5):705-12. PubMed ID: 23048052 [TBL] [Abstract][Full Text] [Related]
30. Impact of antithrombotic treatment on short-term outcomes after percutaneous coronary intervention for left main disease: a pooled analysis from REPLACE-2, ACUITY, and HORIZONS-AMI trials. Geisler T; Müller K; Karathanos A; Bocksch W; Gawaz M; Deliargyris E; Bernstein D; Lincoff AM; Mehran R; Dangas G; Stone GW EuroIntervention; 2014 May; 10(1):97-104. PubMed ID: 24048204 [TBL] [Abstract][Full Text] [Related]
31. Efficacy and Safety of Bivalirudin During Percutaneous Coronary Intervention in Chronic Total Occlusion: A Retrospective Study. Zhang Y; Zhang Y; Chang C; Yan S; Chen Z; Zhang L; Chen K; Liu G Clin Ther; 2021 May; 43(5):844-851. PubMed ID: 33810894 [TBL] [Abstract][Full Text] [Related]
32. Economic impact of switching to bivalirudin for a primary percutaneous coronary intervention in a US hospital. Olchanski N; Slawsky KA; Plent S; Kado C; Cyr PL Hosp Pract (1995); 2010 Nov; 38(4):138-46. PubMed ID: 21068538 [TBL] [Abstract][Full Text] [Related]
33. Bleeding risk and outcomes of Bivalirudin versus Glycoprotein IIb/IIIa inhibitors with targeted low-dose unfractionated Heparin in patients having percutaneous coronary intervention for either stable or unstable angina pectoris. Steinberg DH; Shah P; Kinnaird T; Pinto Slottow TL; Roy PK; Okabe T; Bonello L; de Labriolle A; Smith KA; Torguson R; Xue Z; Suddath WO; Kent KM; Satler LF; Pichard AD; Lindsay J; Waksman R Am J Cardiol; 2008 Jul; 102(2):160-4. PubMed ID: 18602514 [TBL] [Abstract][Full Text] [Related]
34. Bivalirudin versus Heparin plus Glycoprotein IIb/IIIa Inhibitors in Women Undergoing Percutaneous Coronary Intervention: A Meta-Analysis of Randomized Controlled Trials. Xu H; Wang B; Yang J; Ma S; Xie X PLoS One; 2017; 12(1):e0169951. PubMed ID: 28095453 [TBL] [Abstract][Full Text] [Related]
35. Bivalirudin versus heparin for percutaneous coronary intervention: an updated meta-analysis of randomized controlled trials. Lipinski MJ; Lhermusier T; Escarcega RO; Baker NC; Magalhães MA; Torguson R; Suddath WO; Satler LF; Pichard AD; Waksman R Cardiovasc Revasc Med; 2014; 15(6-7):315-22. PubMed ID: 25440505 [TBL] [Abstract][Full Text] [Related]
36. Heparin Versus Bivalirudin in Contemporary Percutaneous Coronary Intervention: A Welcome Back to an Old Friend Unfractionated Heparin. Centurión OA Crit Pathw Cardiol; 2015 Jun; 14(2):62-6. PubMed ID: 26102015 [TBL] [Abstract][Full Text] [Related]